Home › Funds › Sapience Investments, LLC › EYE
Sapience Investments, LLC position in EYE
NATIONAL VISION HLDGS INC · Health Care
Sapience Investments, LLC reported holding 229 shares of EYE (NATIONAL VISION HLDGS INC) in its Q1 2026 13F filing — a position valued at US$6K, representing 0.77% of its reported portfolio and ranking #48 among its reported holdings. Sapience Investments, LLC has disclosed EYE holdings in 10 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Sapience Investments, LLC's EYE position evolved
Sapience Investments, LLC first disclosed a stake in EYE in Q3 2023 at 440,549 shares (US$7.1M). The position peaked in Q4 2023 at 413,670 shares, worth US$8.7M. Across 10 filings, Sapience Investments, LLC increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q1 2026) shows 229 shares valued at US$6K — a reduction of -15,743 shares quarter over quarter.. Notable position changes include a 49% trim in Q2 2025 (shares rose 27% over the following quarter), a 83% trim in Q3 2025 (shares fell 12% over the following quarter), a 99% trim in Q1 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 440.55K | $7.13M | New |
| Q4 2023 | 413.67K | $8.66M | Reduce |
| Q1 2024 | 280.33K | $6.21M | Reduce |
| Q3 2024 | 258.88K | $2.82M | Reduce |
| Q4 2024 | 218.46K | $2.28M | Reduce |
| Q1 2025 | 189.54K | $2.42M | Reduce |
| Q2 2025 | 96.57K | $2.22M | Reduce |
| Q3 2025 | 16.00K | $467.10K | Reduce |
| Q4 2025 | 15.97K | $412.40K | Hold |
| Q1 2026 | 229 | $5.93K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EYE and 13F data
EYE (NATIONAL VISION HLDGS INC) is a Health Care company. 31 other funds we track also report a position in EYE — the largest reported positions include Engine Capital Management, LP (US$66.9M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$59.0M), EMERALD ADVISERS, LLC (US$38.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EYE
- Engine Capital Management, LP 3.52M sh · $66.93M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 3.10M sh · $58.95M · Q2 2026
- EMERALD ADVISERS, LLC 2.01M sh · $38.15M · Q2 2026
- Divisadero Street Capital Management, LP 1.90M sh · $36.11M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.30M sh · $24.68M · Q2 2026
More on Sapience Investments, LLC
FAQ
How long has Sapience Investments, LLC held EYE?
Sapience Investments, LLC has disclosed EYE holdings in 10 of the last 11 reported quarters, going back to Q3 2023.
What is Sapience Investments, LLC's current position in EYE?
As of Q1 2026, Sapience Investments, LLC holds 229 shares of EYE (NATIONAL VISION HLDGS INC), valued at $5.93K, representing 0.77% of its reported portfolio and ranking #48.
Has Sapience Investments, LLC been buying or selling EYE?
In the latest 13F filing (Q1 2026), Sapience Investments, LLC reduced its position in EYE. The position peaked in Q4 2023 at 413.67K shares.
Which other funds hold EYE?
Other major institutional holders of EYE include Engine Capital Management, LP, GLENVIEW CAPITAL MANAGEMENT, LLC, EMERALD ADVISERS, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.